All treatments
Treatment
TAK-279 placebo (same excipient as TAK-279) clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects with Moderate-to-Severe Plaque Psoriasis
This study is testing a new drug, TAK-279, for people with moderate to severe plaque psoriasis. We want to see if it's safe and effective compared to a known treatment (Otezla) and a dummy pill (placebo) to help clear up skin patches.
For: Moderate to Severe Plaque PsoriasisPoland · Italy · Germany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study With a Randomized Withdrawal and Retreatment Period to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects With Moderate-to-Severe Plaque Psoriasis
This study is testing a new medicine, ZASOCITINIB (also called TAK-279), for people with moderate to severe plaque psoriasis. It compares the new medicine to existing treatments like Otezla and a dummy pill (placebo) to see how well it works and if it's safe.
For: Moderate to Severe Plaque PsoriasisGermany · Poland · Latvia